• SMAIO expanded its North American Scientific Advisory Board with appointment of orthopedic spine surgeon Dr. Jeffrey M. Hills, targeting faster growth in US complex spine surgery market.
• Board now has five members, positioned to steer technology roadmap, clinical validation, collaborations tied to SMAIO’s US open platform KEOPS-4ME.
• Remuneration centered on 25,000 share subscription warrants issued to Hills at €4.07 per warrant, exercisable into 25,000 ordinary shares at €7.78 per share.
• Full exercise would add 25,000 shares, about 0.41% of current share capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SMAIO SA published the original content used to generate this news brief on May 11, 2026, and is solely responsible for the information contained therein.